Methods of use of antimicrobial compounds against pathogenic mycoplasma bacteria
AssigneeSmithKline Beecham Corporation
InventorsDonna M. Crabb, Lynn B. Duffy, Karen B. Searcy
Life of this patent
Estimating the term…
Abstract
This invention relates, in part, to newly identified methods of using quinolone antibiotics, particularly a gemifloxacin compound against certain pathogenic bacteria.
Claims11
A method for modulating metabolism of pathogenic Mycoplasma bacteria comprising the step of contacting pathogenic Mycoplasma bacteria with an antibacterially effective amount of a composition comprising a gemifloxacin compound, or antibacterially effective derivatives thereof.
A method of treating or preventing a bacterial infection by pathogenic Mycoplasma bacteria comprising the step of administering an antibacterially effective amount of a composition comprising a gemifloxacin compound to a mammal suspected of having or being at risk of having an infection with pathogenic Mycoplasma bacteria.
Dependencies are inferred from the claim text.